Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glutafin gluten free multipurpose white mix
0913271C0BCACAF
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 2,546 |
|
Glutafin gluten free Select multipurpose white mix
0913271C0BCAGAJ
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 1,638 |
|
Glutafin gluten free Select multipurpose fibre mix
0913271C0BCAFAI
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 752 |
|
Glutafin gluten free bread mix
0913271C0BCAAAD
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 567 |
|
Glutafin gluten free wheat free fibre mix
0913271C0BCAHAK
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 480 |
|
Glutafin gluten free fibre bread mix
0913271C0BCABAE
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 454 |
|
Glutafin gluten free Select bread mix
0913271C0BCADAG
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 330 |
|
Glutafin gluten free Select fibre bread mix
0913271C0BCAEAH
|
Glutafin specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913271) | Nutrition and Blood | 223 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.